BIOMAT Database Logo BIOMAT Database Logo

Survival after early treatment for carbamyl phosphate synthetase (CPS) I deficiency associated with increase of intramitochondrial CPS I. 1995

K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Universitätskinderklinik, Münster, Germany.

The basis for the benefit of early treatment in urea-cycle defects might be an increase in intramitochondrial mutant enzyme in hepatocytes in the postnatal period. In two siblings with carbamyl phosphate synthetase I (CPS I) deficiency, immunoreactive CPS I was greatly reduced in the liver and no residual enzyme activity was detectable. The elder child died at age 4 days, before the diagnosis of CPS I deficiency was established, but in the younger child, age 9 months, treatment was initiated on the 2nd day of life when ammonia concentration was moderately increased, and she has survived. Intramitochondrial CPS I was substantially higher in this sibling than in the elder sister. The different outcome in the younger patient was probably attributable to prompt treatment after early diagnosis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008930 Mitochondria, Liver Mitochondria in hepatocytes. As in all mitochondria, there are an outer membrane and an inner membrane, together creating two separate mitochondrial compartments: the internal matrix space and a much narrower intermembrane space. In the liver mitochondrion, an estimated 67% of the total mitochondrial proteins is located in the matrix. (From Alberts et al., Molecular Biology of the Cell, 2d ed, p343-4) Liver Mitochondria,Liver Mitochondrion,Mitochondrion, Liver
D002222 Carbamoyl-Phosphate Synthase (Ammonia) An enzyme that catalyzes the formation of carbamoyl phosphate from ATP, carbon dioxide, and ammonia. This enzyme is specific for arginine biosynthesis or the urea cycle. Absence or lack of this enzyme may cause CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE. EC 6.3.4.16. Carbamoyl Phosphate Synthetase I,CP Synthase I,Carbamoyl-Phosphate Synthetase (Ammonia),Carbamoyl-Phosphate Synthetase I,Carbamoylphosphate Synthetase I,Carbamyl Phosphate Synthase (Ammonia),Carbamyl-Phosphate Synthase (Ammonia),Synthase I, CP,Synthetase I, Carbamoyl-Phosphate,Synthetase I, Carbamoylphosphate
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000592 Amino Acid Metabolism, Inborn Errors Disorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., ACIDOSIS) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life. Amino Acidopathies, Congenital,Amino Acid Metabolism Disorders, Inborn,Amino Acid Metabolism, Inborn Error,Amino Acid Metabolism, Inherited Disorders,Amino Acidopathies, Inborn,Congenital Amino Acidopathies,Inborn Errors, Amino Acid Metabolism,Inherited Errors of Amino Acid Metabolism,Amino Acidopathy, Congenital,Amino Acidopathy, Inborn,Congenital Amino Acidopathy,Inborn Amino Acidopathies,Inborn Amino Acidopathy
D000641 Ammonia A colorless alkaline gas. It is formed in the body during decomposition of organic materials during a large number of metabolically important reactions. Note that the aqueous form of ammonia is referred to as AMMONIUM HYDROXIDE.

Related Publications

K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
[Carbamyl phosphate synthetase I deficiency].
January 1998, Ryoikibetsu shokogun shirizu,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
[Carbamyl phosphate synthetase I deficiency].
April 1988, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Siblings with carbamyl phosphate synthetase I deficiency.
July 1984, Acta pathologica japonica,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Successful treatment of severe carbamyl phosphate synthetase I deficiency.
December 1984, Archives of disease in childhood,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Genetic analysis of carbamyl phosphate synthetase I deficiency.
January 1985, Human genetics,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Carbamyl phosphate synthetase I deficiency with no detectable mRNA activity.
October 1986, European journal of pediatrics,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Cognitive functioning in two sisters with carbamyl phosphate synthetase I deficiency.
June 1981, Journal of pediatric psychology,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Late clinical presentation of partial carbamyl phosphate synthetase I deficiency.
March 1993, American journal of diseases of children (1960),
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
[Hyperammonemia: partial carbamyl phosphate synthetase deficiency].
August 1982, Orvosi hetilap,
K P Zimmer, and H Y Naim, and H G Koch, and J P Colombo, and R Rossi, and K W Schmid, and T Deufel, and K Ullrich, and E Harms
Carbamyl phosphate synthetase deficiency with lethal neonatal outcome.
September 1982, European journal of pediatrics,
Copied contents to your clipboard!